s6y

VACCINEX, INC.

Ticker
VCNX
CIK
1205922
Industry
Pharmaceutical Preparations
Formerly
VACCINEX INC

Financials 31

  1. 10-K Annual Report for period ending Dec 31, 2024
  2. NT 10-K Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10-KT for period ending Mar 31, 2025
  3. 10-Q Quarterly Report for period ending Sep 30, 2024
  4. 10-Q Quarterly Report for period ending Jun 30, 2024
  5. 10-Q Quarterly Report for period ending Mar 31, 2024
  6. 10-K/A Annual Report for period ending Dec 31, 2023
  7. NT 10-K Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10-KT for period ending Dec 31, 2023
  8. 10-K Annual Report for period ending Dec 31, 2023
  9. 10-Q Quarterly Report for period ending Sep 30, 2023
  10. 10-Q Quarterly Report for period ending Jun 30, 2023

All 31 financials filings

News 77

  1. 8-K Current report filing
  2. 8-K Current report filing
  3. 8-K Current report filing
  4. 8-K Current report filing
  5. 8-K Current report filing
  6. 8-K Current report filing
  7. 8-K Current report filing
  8. 8-K Current report filing
  9. 8-K Current report filing
  10. 8-K Current report filing

All 77 news filings

Ownership 204

  1. SC 13D/A Major Shareholders
  2. 4 Statement of changes in beneficial ownership of securities
  3. 4 Statement of changes in beneficial ownership of securities
  4. SC 13G Major Shareholders
  5. SC 13D/A Major Shareholders
  6. SC 13D/A Major Shareholders
  7. 4 Statement of changes in beneficial ownership of securities
  8. 4 Statement of changes in beneficial ownership of securities
  9. 4 Statement of changes in beneficial ownership of securities
  10. SC 13D/A Major Shareholders

All 204 ownership filings

Prospectus 48

  1. S-8 POS Post-effective amendment to a S-8 registration statement
  2. S-8 POS Post-effective amendment to a S-8 registration statement
  3. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  4. S-3 Registration statement for specified transactions by certain issuers
  5. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  6. S-3 Registration statement for specified transactions by certain issuers
  7. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  8. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  9. S-3/A Registration statement for specified transactions by certain issuers
  10. S-3 Registration statement for specified transactions by certain issuers

All 48 prospectus filings

Proxies 10

  1. DEF 14A Definitive proxy statements
  2. DEF 14A Definitive proxy statements
  3. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  4. DEF 14A Definitive proxy statements
  5. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  6. DEF 14A Definitive proxy statements
  7. DEF 14A Definitive proxy statements
  8. DEF 14A Definitive proxy statements
  9. DEF 14A Definitive proxy statements
  10. DEF 14A Definitive proxy statements

Other 105

  1. 15-12G Notice of termination of registration of a class of securities under Section 12(g)
  2. EFFECT Notice of Effectiveness
  3. EFFECT Notice of Effectiveness
  4. EFFECT Notice of Effectiveness
  5. EFFECT Notice of Effectiveness
  6. EFFECT Notice of Effectiveness
  7. EFFECT Notice of Effectiveness
  8. EFFECT Notice of Effectiveness
  9. EFFECT Notice of Effectiveness
  10. EFFECT Notice of Effectiveness

All 105 other filings